Topics / Endocrinology

Weekly issue

Endocrinology Papers of the Week

The top Endocrinology papers of the week: the 20 most important new papers of the past week, ranked by potential impact. A new issue comes out every Monday, covering the previous Monday-to-Sunday week.

Nov 9 - 15, 2026 · Updated

Prefer new papers every day? It's free.Endocrinology Daily Papers →
  1. 1
  2. 2
    Metabolic Severity and Early Disease Course in Children with Newly Diagnosed Type 1 Diabetes Mellitus According to Prior SARS-CoV-2 Infection Status: A Retrospective Cohort Study

    Although an increased frequency of diabetic ketoacidosis (DKA) has been reported during the coronavirus disease 2019 (COVID-19) pandemic, it is unclear whether this reflects a direct pathogenic role of the virus or indirect effects related to healthcare access and delayed presentation. Methods: This retrospective study included children with newly diagnosed T1DM evaluated between 2021 and 2025 at a single tertiary pediatric center.

  3. 3
  4. 4
  5. 5
    Online Co-care Management and Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Propensity Score-matched Retrospective Cohort Study

    Based on clinical follow-up records, we conducted a retrospective cohort study with a propensity score (PS)-matched control group.The OCCM group included patients enrolled in the integrated care clinic from 2022 to 2025 (n = 406).

Get papers like these the day they come out, not a week later.

Follow this category
  1. 6
  2. 7
    Trends in Inflation-Adjusted Pharmacotherapy Costs and Cardiovascular Risk Factor Management in Type 2 Diabetes: A 26-Year Study from Tertiary Diabetes Cen​​​​tres in Greece ​​​

    We evaluated long-term trends in pharmacotherapy costs and cardiovascular risk factor target achievement among people with type 2 diabetes attending tertiary diabetes centres in Greece. This periodic, multicenter, cross-sectional study analysed data from 4,963 people with type 2 diabetes attending three diabetes centres at specific time points: 1998, 2006, 2012, 2018, and 2024.

  3. 8
    A Transcriptional and Cellular Exploration of Obesity and Type II Diabetes in Human Adipose Tissues

    We identified reprogramming of the omental stromal compartment, centered on mesothelial and endothelial cells, alongside contrasting innate T cell and macrophage phenotypes across depots.

  4. 9
  5. 10
    DEVELOPMENT AND CONTENT VALIDATION OF A MOBILE APPLICATION FOR CLINICAL ASSESSMENT AND DIABETIC FOOT PREVENTION IN PRIMARY HEALTH CARE

    This methodological study focused on the development and validation of a health technology and was conducted between August 2024 and August 2026.

  6. 11
    Fractal-Fractional Diabetes Mellitus Model Without Genetic Influences: Numerical Investigations

    In this study, we present an accurate simulation to examine the behavior of solutions to the mathematical model of diabetes without genetic factors (MMDWGF) in its fractal-fractional form.

  7. 12
    Should Romosozumab Be Used in Patients with A History or Risk of CVD?

    Observational studies generally report no increased risk compared with other osteoporosis treatments, including in some patients with previous cardiovascular events.

  8. 13
    Insulin Genetic Clusters and Clinical Outcomes in Hispanics/Latinos

    We calculated seven previously developed FI cluster-specific PS, including non-diabetogenic (Preserved Insulin Secretion, Elevated Insulin Secretion, Proinsulin) and diabetogenic clusters (Adiposity-driven Hyperinsulinemia, Visceral Adiposity, Lipodystrophy, Liver/Lipid) in 12,631 participants of the Hispanic Community Healthy Study/Study of Latinos (HCHS/SOL), and tested their association with type 2 diabetes, cardiovascular, kidney and liver outcomes.

  9. 14
    Cardiovascular Risk, Evaluation and Management in Patients with Hypertriglyceridaemia: A Consensus Statement from The International Atherosclerosis Society

    However, so far, there is no evidence from randomized clinical trials that pharmacotherapies targeting triglycerides can reduce the occurrence of cardiovascular events, suggesting that elevated levels of triglycerides serve as a marker of atherosclerotic risk that should prompt optimization of modifiable cardiovascular risk factors. In this Consensus Statement, we provide clinical context and evidence for the evaluation, diagnosis and management of hypertriglyceridaemia.

  10. 15
    Cessation of Hemodialysis Among End-Stage Kidney Disease Patients Following Recovery of Kidney Function

    Objective: To identify ESKD patients who discontinued MHD following RKF. Methods: This retrospective cross-sectional study was conducted at Shahida Islam Medical College, Lodhran, and Bahawal Victoria Hospital, Bahawalpur, Pakistan, from January 2022 to January 2025.

  11. 16
  12. 17
    Muscle Lipid Localization Relates to Insulin Sensitivity: Responses to Exercise and Weight Loss Interventions

    This suggests interventions may need to occur earlier, before prediabetes or type 2 diabetes develops, or that lipid localization responds rapidly to acute changes in energy balance and physical activity that may not be captured following typical weight loss or exercise training interventions. To address this gap, we assessed the effect of acute and chronic insulin-sensitizing interventions across a spectrum of metabolic health in three separate studies.

  13. 18
  14. 19
    Phase 3 Clinical Development of Semaglutide (2015-2026): A Comprehensive Evidence-based Review of Trial Designs, Therapeutic Outcomes and Global Clinical Experience

    This review critically evaluates Phase 3, Phase 3a, and Phase 3b clinical trials (CTs) assessing the efficacy, safety and therapeutic utility of semaglutide, with an emphasis on the SUSTAIN, PIONEER, STEP, SELECT, FLOW, SOUL and related programmes.

  15. 20